German Pharma Giant Awards ZeroStack $6.5M Distribution Contract
Summary
ZeroStack Corp. announced a significant $6.5 million order from a major pharmaceutical company for distribution services in Germany, to be fulfilled by its wholly-owned subsidiary, Phatebo GmbH. This highly material order, representing over 40% of ZeroStack's current market capitalization of approximately $15.65 million, provides a crucial positive revenue stream. It comes shortly after the company reported a substantial $119.7 million net loss for 2025 in its recent 10-K filing, primarily due to digital asset revaluation. Phatebo GmbH is identified as the company's largest revenue contributor, making this contract vital for its financial performance and cash flow. Investors will be watching for the impact of this order on ZeroStack's upcoming financial results and whether the company can secure further high-value distribution contracts to stabilize its revenue base and offset losses from its digital asset holdings.
At the time of this announcement, ZSTK was trading at $6.44 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $15.7M. The 52-week trading range was $5.86 to $1,201.59. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: TMX Newsfile.